Destiny Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Destiny Wealth Partners's FBT Position: Q2 2026 in Review
Destiny Wealth Partners sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 1,938 shares — an estimated $389K sold.
Destiny Wealth Partners first reported a position in FBT in Q1 2021 and held it in 21 quarters. The position peaked at $489K in Q2 2021. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Destiny Wealth Partners reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
- Destiny Wealth Partners sold 1,938 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $389K.
- Destiny Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2021 and held it in 21 quarters.
- Destiny Wealth Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $489K in Q2 2021.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.